Companies / 3T Biosciences
3T Biosciences
Company
3T Biosciences is an immunotherapy company developing next-generation therapies for the treatment of solid tumors and other immune-mediated diseases
3T Biosciences has 6 investors on file, among them Asset Management Company, Collaborative Fund and CRV. Its site was last checked 13 Nov 2026: site answers.
Investors
6 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get 3T Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Asset Management Company adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/3tbiosciences.com/investors
# also
GET /v1/companies/3tbiosciences.com
GET /v1/companies/3tbiosciences.com/news